The global burden of lung cancer: current status and future trends

A Leiter, RR Veluswamy, JP Wisnivesky - Nature reviews Clinical …, 2023 - nature.com
Lung cancer is the leading cause of cancer-related death worldwide. However, lung cancer
incidence and mortality rates differ substantially across the world, reflecting varying patterns …

[HTML][HTML] Global epidemiology of lung cancer

JA Barta, CA Powell, JP Wisnivesky - Annals of global health, 2019 - ncbi.nlm.nih.gov
While lung cancer has been the leading cause of cancer-related deaths for many years in
the United States, incidence and mortality statistics–among other measures–vary widely …

Global initiative for chronic obstructive lung disease 2023 report: GOLD executive summary

A Agustí, BR Celli, GJ Criner, D Halpin… - European …, 2023 - publications.ersnet.org
Global Initiative for Chronic Obstructive Lung Disease 2023 Report: GOLD Executive Summary |
European Respiratory Society Skip to main content Top Menu ERS website Respiratory …

Comorbidities and risk of mortality in patients with chronic obstructive pulmonary disease

M Divo, C Cote, JP de Torres, C Casanova… - American journal of …, 2012 - atsjournals.org
Rationale: Patients with chronic obstructive pulmonary disease (COPD) are afflicted by
comorbidities. Few studies have prospectively evaluated COPD comorbidities and mortality …

Comorbidities of COPD

A Cavaillès, G Brinchault-Rabin… - European …, 2013 - Eur Respiratory Soc
By 2020, chronic obstructive pulmonary disease (COPD) will be the third cause of mortality.
Extrapulmonary comorbidities influence the prognosis of patients with COPD. Tobacco …

Epidemiology and clinical impact of major comorbidities in patients with COPD

MC Smith, JP Wrobel - International journal of chronic obstructive …, 2014 - Taylor & Francis
Comorbidities are frequent in chronic obstructive pulmonary disease (COPD) and
significantly impact on patients' quality of life, exacerbation frequency, and survival. There is …

“Sentinel” circulating tumor cells allow early diagnosis of lung cancer in patients with chronic obstructive pulmonary disease

M Ilie, V Hofman, E Long-Mira, E Selva, JM Vignaud… - PloS one, 2014 - journals.plos.org
Chronic obstructive pulmonary disease (COPD) is a risk factor for lung cancer. Migration of
circulating tumor cells (CTCs) into the blood stream is an early event that occurs during …

An official American Thoracic Society/European Respiratory Society statement: research questions in chronic obstructive pulmonary disease

BR Celli, M Decramer, JA Wedzicha… - American journal of …, 2015 - atsjournals.org
Background: Chronic obstructive pulmonary disease (COPD) is a leading cause of
morbidity, mortality, and resource use worldwide. The goal of this Official American Thoracic …

Chronic obstructive pulmonary disease and comorbidities

M Decramer, W Janssens - The Lancet Respiratory Medicine, 2013 - thelancet.com
Results of epidemiological studies have shown that chronic obstructive pulmonary disease
(COPD) is frequently associated with comorbidities, the most serious and prevalent being …

Epithelial–mesenchymal transition, a spectrum of states: role in lung development, homeostasis, and disease

MK Jolly, C Ward, MS Eapen, S Myers… - Developmental …, 2018 - Wiley Online Library
Epithelial–mesenchymal transition (EMT) plays key roles during lung development and
many lung diseases such as chronic obstructive pulmonary disease (COPD), lung cancer …